HCV Antiviral Drugs Have the Potential to Adversely Perturb the Fetal-Maternal Communication Axis through Inhibition of CYP3A7 DHEA-S Oxidation Hannah M. Work, John C. Hackett, Jed N. Lampe Drug Metabolism and Disposition.2024; 52(6): 516. CrossRef
Hepatitis C Virus: History and Current Knowledge Skender Topi, Elona Gaxhja, Ioannis Alexandros Charitos, Marica Colella, Luigi Santacroce Gastroenterology Insights.2024; 15(3): 676. CrossRef
Antivirals virtual screening to SARS-CoV-2 non-structural proteins Vinicius S. Nunes, Diego F. S. Paschoal, Luiz Antônio S. Costa, Hélio F. Dos Santos Journal of Biomolecular Structure and Dynamics.2022; 40(19): 8989. CrossRef
Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Francis O. Atanu, Gaber El-Saber Batiha Biomedicine & Pharmacotherapy.2021; 143: 112193. CrossRef
Yu Jun Wong, Si Yuan Chew, John Chen Hsiang, Prem Harichander Thurairajah, Rahul Kumar, Eng Kiong Teo, Roshni Sadashiv Gokhale, Imran Bin Mohamed Noor, Jessica Tan
Clin Mol Hepatol 2019;25(2):218-222. Published online September 6, 2018